Net Income

Immunome is using strategic stock grants to lure top talent. We analyze why this move is critical for its pipeline and what it means for investors.

With its CFO departing after a major strategic pivot, AAR CORP. names a 13-year insider as his interim replacement. What does this signal for investors?

With $15M in new funding and seasoned mining execs on board, Getty Copper is now debt-free and poised to unlock the potential of its vast copper assets.

Promising Phase 3 data reveals a novel, organ-sparing laser therapy for a rare cancer, signaling a potential paradigm shift away from radical surgery.

Bitwise appoints a new data VP amid a frenzied AI market. But can one leader bridge the gap between massive spending and measurable business results?

A class action lawsuit against Telix Pharmaceuticals reveals the perilous gap between optimistic corporate disclosures and harsh regulatory setbacks.

Booking data reveals a shift in luxury travel towards privacy and curated experiences, forcing a supply chain evolution for those who cater to the elite.

While official data points to growth, new metrics reveal nearly 25% of workers are functionally unemployed, exposing a deep affordability crisis.

A promising fintech's complex arbitrage strategy collapses, triggering a stock crash, CEO exit, and a wave of securities fraud investigations.

SoftBank's move to delist French robotics firm BALYO offers a premium to shareholders but signals a larger consolidation in the automated logistics space.

MicroCloud Hologram is betting $400M on a quantum-driven 3D model. Is it a revolutionary leap for digital creation or a costly gamble on unproven tech?

Beyond a massive cookie giveaway, Dirty Dough is engineering loyalty and fueling franchise growth. Here's the strategy behind their 'Free for Life' campaign.

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

Beyond the award, we explore Diebold Nixdorf's ESG data, the rise of corporate responsibility rankings, and why sustainability is now core business strategy.

A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.

A landmark deal between a defense giant and a tech titan is set to revolutionize space operations. Here's why the future of national security is in the cloud.

The battery innovator secures fresh capital to scale its 'One-Pot' process. We analyze if this move signals a turning point for investors and the EV market.

A breakthrough stem cell study extends hope for stroke recovery. But a supplement brand is using it to sell 'detox' pills. We separate the facts from fiction.

Canada's top tire distributor is restructuring for global conquest. A deep dive into the new Touchette Corporation, the leaders driving it, and its M&A ambitions.

A major CRO presents 10 pivotal studies at the world's top blood disease meeting, revealing a strategy built on real-world data and collaborative innovation.